Louisiana's new law reclassifies mifepristone and misoprostol as Schedule IV substances, complicating access to crucial medications for both abortion and emergency medical care.
OB-GYNs express that the law creates confusion and angst, risking the loss of essential medications that could save women's lives.
[
Collection
]
[
|
...
]